Cullinan Therapeutics, Inc.

CGEM - CIK 0001789972

Market cap$740.57 M

Rank#2664

SEC filings435

Cullinan Therapeutics, Inc. has filed 435 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (209 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Filing	Type	Filed	Period covered
EFFECT	-	2021-01-07	-
Exchange certification	CERT	2021-01-07	-
S-1MEF	-	2021-01-07	-
Employee stock plan	S-8	2021-01-07	-
New insider ownership	3	2021-01-07	2021-01-07
New insider ownership	3	2021-01-07	2021-01-07
New insider ownership	3	2021-01-07	2021-01-07
New insider ownership	3	2021-01-07	2021-01-07
New insider ownership	3	2021-01-07	2021-01-07
New insider ownership	3	2021-01-07	2021-01-07
New insider ownership	3	2021-01-07	2021-01-07
New insider ownership	3	2021-01-07	2021-01-07
New insider ownership	3	2021-01-07	2021-01-07
New insider ownership	3	2021-01-07	2021-01-07
New insider ownership	3	2021-01-07	2021-01-07
New insider ownership	3	2021-01-07	2021-01-07
New insider ownership	3	2021-01-07	2021-01-07
New insider ownership	3	2021-01-07	2021-01-07
Company correspondence	CORRESP	2021-01-06	-
S-1/A	-	2021-01-06	-
8-A12B	-	2021-01-06	-
SEC correspondence	UPLOAD	2021-01-05	-
Company correspondence	CORRESP	2021-01-04	-
Company correspondence	CORRESP	2021-01-04	-
S-1/A	-	2021-01-04	-
S-1/A	-	2020-12-28	-
Company correspondence	CORRESP	2020-12-18	-
Company correspondence	CORRESP	2020-12-18	-
IPO registration	S-1	2020-12-18	-
SEC correspondence	UPLOAD	2020-12-18	-
DRSLTR	-	2020-12-09	-
DRS/A	-	2020-12-09	-
SEC STAFF LETTER	-	2020-12-03	-
SEC correspondence	UPLOAD	2020-12-01	-
DRS	-	2020-11-02	-